Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of two traditional herbal medicines widely used in East Asian medicine—Panax ginseng (Ginseng radix) and Bupleurum root (Bupleuri radix). Both herbs are known for their immunomodulatory, anti-inflammatory, hepatoprotective, and adaptogenic properties. In preclinical studies, the combination has been shown to increase the amplitude of spontaneous activity in lymphatic vessels and enhance lymph flow independently of endothelial cells. The active constituents include ginsenosides from Panax ginseng and saikosaponins from Bupleurum root. These compounds have demonstrated effects such as modulation of immune function, anti-inflammatory action via inhibition of pro-inflammatory cytokines and mediators, antiviral activity against enveloped viruses (for bupleurum), hepatoprotection through antioxidant mechanisms, and possible metabolic benefits. This combination is primarily used in traditional medicine formulas for supporting immune health, liver function, stress adaptation, and general vitality[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginseng + radix bupleuri.